When evaluating where to order CJC-1295 DAC online for laboratory experimentation, securing verified chemical identity, analytical purity, and lot-to-lot consistency is essential. PX1 Research supplies high-purity CJC-1295 DAC synthesized in USA-based, GMP-compliant facilities with comprehensive third-party COAs for qualified research institutions.
When evaluating where to order CJC-1295 DAC online for laboratory experimentation, securing verified chemical identity, analytical purity, and lot-to-lot consistency is essential. PX1 Research supplies high-purity CJC-1295 DAC synthesized in USA-based, GMP-compliant facilities with comprehensive third-party COAs for qualified research institutions.
To order CJC-1295 DAC online for laboratory research, investigators must select supplier platforms that guarantee analytical verification through lot-specific Certificate of Analysis (COA) documents. High-purity CJC-1295 DAC should be manufactured under rigorous quality control standards, utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) to confirm greater than 99% peptide purity and accurate molecular weight.
PX1 Research provides researchers with direct access to USA-manufactured cjc-1295 dac engineered exclusively for in vitro and preclinical laboratory applications. Every lot undergoes independent third-party analytical testing, ensuring precise concentration, low endotoxin thresholds (<0.5 EU/mg), and structural stability across all experimental assays.
CJC-1295 DAC (Drug Affinity Complex) is a synthetic 30-amino acid analog of natural Growth Hormone-Releasing Hormone (GHRH). By incorporating a bioconjugative maleimido-propionic acid group at the C-terminus, the molecule irreversibly binds to endogenous serum albumin following administration in animal models. This covalent modification protects the peptide sequence from rapid enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV).
Through this extended half-life mechanism, CJC-1295 DAC continuously stimulates anterior pituitary somatotrophs via GHRH receptor activation. Preclinical research indicates that this sustained receptor engagement promotes continuous, non-pulsatile secretion of growth hormone (GH), which subsequently elevates systemic insulin-like growth factor 1 (igf-1 axis in tissue repair) levels over extended observation periods.
The inclusion of the Drug Affinity Complex dramatically alters the pharmacokinetic profile of standard GHRH analogs. Unmodified GHRH peptides typically exhibit circulating half-lives measured in minutes due to rapid renal clearance and enzymatic degradation. In contrast, pharmacokinetic studies in rodent and canine models demonstrate that CJC-1295 with DAC maintains biological activity with an extended elimination half-life ranging from 6 to 8 days.
This prolonged half-life allows researchers to design experimental protocols without the confounding variable of rapid concentration decay. For investigative laboratories studying long-term endocrine signaling, tissue turnover, or cellular regeneration, ordering CJC-1295 DAC provides a steady state of physiological stimulus, reducing handling stress in animal subjects during longitudinal trials.
In vitro data and rodent model studies demonstrate that CJC-1295 DAC systematically activates the growth hormone axis. Research published in endocrinology literature shows that a single administration in animal models results in a sustained 2- to 4-fold elevation in baseline GH levels, accompanied by a sustained 3- to 10-fold increase in circulating IGF-1 concentrations lasting up to 14 days.
Preclinical evidence suggests that this sustained elevation of downstream IGF-1 play a crucial role in cell proliferation, extracellular matrix synthesis, and protein translation models. Investigators frequently study this compound within research models targeting cellular repair, musculoskeletal regeneration, and body composition modulation in metabolic disease research.
When designing research studies involving pituitary somatotroph secretagogues, selecting the appropriate molecule depends on the targeted biological half-life and pulse dynamic required by the protocol. Researchers looking across our full catalog of all peptides often compare CJC-1295 DAC against shorter-acting signaling peptides.
For instance, cjc-1295 no dac lacks the albumin-binding complex, yielding a shorter half-life (approximately 30 minutes) that mimics natural episodic GH pulses. Similarly, sermorelin represents a truncated 29-amino acid GHRH fragment with rapid degradation kinetics ideal for acute stimulation assays. Alternatively, structural analogs like tesamorelin offer targeted GHRH receptor selectivity with intermediate clearance rates. Combining GHRH analogs with ghrelin receptor agonists such as ipamorelin is also widely documented in literature exploring synergistic somatotroph activation.
Because synthetic peptide stability can be compromised by trace impurities or synthesis failures, analytical validation is critical prior to initiating laboratory experiments. When you order CJC-1295 DAC online from PX1 Research, each vial is backed by fully transparent third-party verification.
Our quality control workflow mandates RP-HPLC analysis to confirm purity thresholds above 99.0%, accompanied by Mass Spectrometry to verify exact monoisotopic mass. Furthermore, every batch undergoes chromogenic LAL assays to ensure endotoxin levels remain strictly under <0.5 EU/mg. Researchers can inspect batch-specific documentation in our dedicated research library hub prior to procuring materials for trial series.
CJC-1295 DAC is supplied as a lyophilized (freeze-dried) cake or powder to ensure chemical stability during transport and storage. To maintain structural integrity, un-reconstituted vials should be stored at -20°C in a dry environment protected from direct light.
Reconstitution protocols in laboratory environments typically utilize Bacteriostatic Water (0.9% benzyl alcohol) or sterile PBS depending on assay specifications. When adding solvent, gently direct the liquid down the inner glass wall of the vial rather than directly onto the lyophilized plug. Swirl gently to dissolve; never vortex or agitate vigorously, as shear force can induce peptide denaturation or aggregation. Post-reconstitution, liquid aliquots should be refrigerated at 2°C to 8°C and used within defined experimental windows.
Principal investigators, academic institutions, and contract research organizations (CROs) requiring large volumes of standardized compounds can access bulk options through our wholesale laboratory program. Institutional procurement ensures consistent lot availability, reducing experimental variation across longitudinal study designs.
All shipments originate directly from our ISO 17025 accredited and GMP-compliant distribution facilities located in California and Arizona. Orders processed Monday through Friday before 12:00 PM PST ship same-day, arriving in temperature-controlled packaging designed to protect peptide stability throughout transit.
What is the primary difference between CJC-1295 DAC and CJC-1295 No DAC?
CJC-1295 DAC contains a Drug Affinity Complex (maleimido-propionic acid) that covalently binds to serum albumin, extending its biological half-life to several days in animal models. CJC-1295 No DAC lacks this complex and exhibits a much shorter half-life of roughly 30 minutes.
How is CJC-1295 DAC analytical purity verified?
PX1 Research verifies CJC-1295 DAC using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity (>99%) and Mass Spectrometry (MS) to confirm molecular structure and mass accuracy.
What endotoxin levels are acceptable for CJC-1295 DAC in research settings?
High-purity laboratory grade CJC-1295 DAC from PX1 Research is tested via chromogenic LAL assay to guarantee endotoxin levels remain below 0.5 EU/mg, minimizing non-specific inflammatory responses in cellular assays.
How should lyophilized CJC-1295 DAC be stored upon delivery?
Lyophilized CJC-1295 DAC should be stored at -20°C upon receipt to maintain long-term stability. Once reconstituted, solutions should be kept refrigerated at 2°C to 8°C and used promptly according to laboratory protocols.
What mechanism allows CJC-1295 DAC to elevate IGF-1 levels?
CJC-1295 DAC acts as a GHRH receptor agonist, continuously stimulating pituitary somatotrophs to synthesize and release growth hormone, which subsequently triggers hepatic synthesis of IGF-1.
Can CJC-1295 DAC be ordered in bulk for institutional research accounts?
Yes, PX1 Research offers institutional accounts and bulk supply for qualified universities, CROs, and private research labs via our wholesale procurement channel.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.